南化硫酸渣磁化焙烧-磁选工艺的研究

为硫酸 渣的综合 利用和环 境保护 ，通过回 转窑 和磁 选机 对南 化硫 酸渣 进行 磁 化焙 烧 磁选，在精矿 产率约 ６５ ％ 、铁元素回 收率约 ８０ ％ 的前提 条 件下 ，可 以生 产出 含 铁品 位约 ６３ ％ 、各 种 物理化学性 能完全 符合炼铁 工艺要求 的铁精 矿粉，从 而可以有 效地回收 硫酸渣 中的铁元 素     

硝基苯生产废水治理研究与设计

选择铁碳还原 兼氧生化 好氧生化工艺治理硝基苯生产废水工程。初步探讨了铁碳池中硝基苯的降解原因是还原、聚合作用造成的。治污设施运行结果表明 ,进水水质 :CODCr90 0mg L ,硝基苯浓度 15 3mg L ;出水水质 :CODCr<10 0mg L ,硝基苯浓度 <3.0mg L ,达到GB8978 96二级排放标准     

钢铁厂铁鳞、铁红基本物性及还原性研究

对钢铁厂铁鳞、铁红的基本物化性能和还原性能进行了研究。结果表明：粒度较粗、全铁较高铁鳞的还原性较好，适于作为优质海绵铁的原料。粒度极细、全铁高且杂质含量很低的铁红还原性也较好，适于作还原铁粉生产的原料。     

30CrMnSiA钢薄壁筒错距旋压成形工艺研究

通过对30CrMnSiA钢筒体错距旋压试验,系统研究了毛坯厚度、减薄率、旋轮压下量分配、旋压道次及道次间热处理等工艺参数对旋压过程和产品质量的影响。结果表明:较厚的30CrMnSiA钢毛坯,不用道次间热处理,通过两道次或三道次错距旋压,就可获得高质量的薄壁筒。     

钢渣处置工艺的清洁生产研究与实施

该课题研究了用水淬法和蒸汽法相结合的技术消除钢渣中的游离氧化钙;用传统的破碎磁选与高精度的强磁选相结合,以独创的递进除铁技术使钢渣中的含铁量由18%降至1%;用专项技术改制的管式磨、活化环,蒸汽熟化,递进式除铁,o-sepa选粉,高频振动粉磨,PPC集料器组成钢渣微粉清洁生产工艺.结果表明该工艺在国内尚属首例,具有较好的推广应用价值.     

自然水体生物膜上铁、锰氧化物生长速率的研究

通过对南湖水体培养的生物膜上铁、锰氧化物生长速率的研究发现，生物膜上铁、锰氧化物的生长过程均属于一级动力学反应，可以用双常数速率方程、Elovich方程、抛物线扩散方程及指数函数方程进行描述，生物膜上铁氧化物的生长速率远远大于锰氧化物的生长速率，锰氧化物的生长速率随水深的增加而降低，并呈显著的线性关系。     

Justification of maternal serum alphafetoprotein screening in a population with low incidence of neural tube defects

A prospective study of maternal serum alphafetoprotein (α-FP) screening of 9838 women in an area with low prevalence of neural tube defects and predominance of anencephalics revealed that an intervention point of single serum α-FP level above 2·8 times the median was appropriate for this population. Ninety per cent of anencephalics and all fetuses with anterior abdominal wall defects were detected. There was no spina bifida among the population screened. Two per cent of the population screened had serum α-FP level above this cut-off level. Thirty-two per cent of twin pregnancies, 7 per cent of small-for-gestational age infants and 9 per cent of pregnancies which ended in either abortion or perinatal death in the population screened also had one serum α-FP level above this intervention point. The false positive rate was 66 per cent. This false positive rate was only reduced to 63 per cent if instead of one, two serum α-FP level above this intervention point was considered abnormal. Using this strategy there was no significant reduction in the detection rate of fetal anomalies and other pregnancy complications. Because of the predominance of anencephalics in this population the diagnosis of fetal anomaly in women with abnormal serum a-FP level was made by ultrasound examination alone. The reason amniocentesis was not performed in these patients was to avoid unnecessary loss of normal pregnancies which may result from this procedure.     

Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal down syndrome

An association between various abnormal mid-trimester maternal serum analyte values and adverse perinatal outcome has been reported. From an original sample of 14 857 women, we observed five women who were ‘screen-positive’ for both neural tube defects [maternal serum alpha-fetoprotein (MSAFP) ≥2·5 multiples of the median] and Down syndrome [risk ≥1/274 using MSAFP, maternal serum unconjugated oestriol (MSuE3), maternal serum human chorionic gonadotropin (MShCG), and maternal age]. The four patients who elected to undergo amniocentesis all demonstrated both normal karyotype and normal amniotic fluid AFP levels. All five cases were associated with intrauterine growth retardation (IUGR) and abnormal pregnancy outcomes. Two cases exhibiting severe IUGR on ultrasound examination were terminated at 19·1 and 21·2 weeks, respectively; the former also exhibited fetal calcifications and positive maternal serology for toxoplasmosis. In another case, fetal demise occurred at 36 weeks' gestation in a patient who had been treated for syphilis in the second trimester. Neither infection was confirmed in fetal tissue studies. Though resulting in live births, the remaining two cases required operative deliveries; emergency Caesarean sections for fetal distress were performed at 38 and 32 weeks, respectively, the latter case being associated with severe pre-eclampsia. We conclude that elevated mid-trimester MSAFP levels concurrent with maternal serum analyte values associated with increased risk for fetal Down syndrome may presage a poor perinatal outcome, particularly IUGR and possibly congenital infection.     

Glial fibrillary acidic protein in amniotic fluids from pregnancies with fetal neural tube defects

The glial fibrillary acidic protein (GFAP) is the subunit protein of intermediate filaments in astrocytes and closely related cell types. By means of an enzyme immunoassay we have determined the concentration of GFAP in amniotic fluids from normal pregnancies and from pregnancies complicated by various fetal malformations. The group of 20 cases of fetal anencephaly had a significantly higher mean amniotic fluid GFAP concentration (115 μg/1±133.6 (S.D.), range 6–378 μg/1) than the control group of 117 normal pregnancies (13 μg/1k±5.5 (S.D.), range 0–31 μg/1), (P<0.001). Two cases of fetal encephalocele likewise had very high amniotic fluid GFAP concentrations. None of the other cases of fetal malformations investigated, including 12 cases of spina bifida, had increased amniotic fluid GFAP concentrations. We conclude that determination of the amniotic fluid GFAP concentration may give additional information in the prenatal diagnosis of fetal nervous system malformations.     

~(57)Fe Mssbauer spectroscopic study on the barks of several three species grown in Lanzhou, China

１ＩｎｔｒｏｄｕｃｔｉｏｎＡｌｔｈｏｕｇｈｆｉｌｔｅｒｍｅｔｈｏｄｉｓｖｅｒｙｔｉｍｅｃｏｎｓｕｍｉｎｇ，ｉｔｈａｓｂｅｅｎｅｍｐｌｏｙｅｄｉｎｔｈｅｉｎｖｅｓｔｉｇａｔｉｏｎｓｏｆａｅｒｏｓｏｌｓｆｏｒａｌｏｎｇｔｉｍｅ（Ｋｏｐｃｅｗｉｃｚ，１９...